Thomas Kalhor
Leukemia, positioning the primary spot in youthful individuals' harmful infections, is the dangerous tumor of hematopoietic framework. As of now, chemotherapy is still a significant treatment strategy for leukemia. However with the utilization of chemotherapy drugs, leukemia cells step by step create opposition coming about in chemotherapy disappointment. The acquired (regular) or procured drug opposition, particularly multidrug opposition (MDR) is viewed as the significant reason for chemotherapy disappointment. In spite of unmistakable components, MDR is generally the helpful impact of a mix of MDR systems like obstructing apoptosis and expanding drug efflux. Among drug efflux carriers, the most broadly examined is adenosine triphosphate-restricting tape (ABC) carriers
இந்தக் கட்டுரையைப் பகிரவும்